NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1083 coverStress, Obesity, and Metabolic Syndrome Volume 1083 published November 2006
Ann. N.Y. Acad. Sci. 1083: 111–128 (2006). doi: 10.1196/annals.1367.009
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by PASQUALI, R.
Articles by PAGOTTO, U.
Search for Related Content
PubMed
PubMed Citation
Articles by PASQUALI, R.
Articles by PAGOTTO, U.

Part II. Central Stress Activity and Peripheral Tissue Sensitivity in the Genesis of Obesity and the Metabolic Syndrome

The Hypothalamic-Pituitary-Adrenal Axis Activity in Obesity and the Metabolic Syndrome

RENATO PASQUALIa, VALENTINA VICENNATIa, MAURO CACCIARIa AND UBERTO PAGOTTOa

a Division of Endocrinology, Department of Internal Medicine, and Centre for Applied Biomedical Research (C.R.B.A.), S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy

Key Words: obesity • hypothalamic-pituitary-adrenal axis • glucocorticoids

Address for correspondence: Renato Pasquali, M.D., Division of Endocrinology, Department of Internal Medicine, S. Orsola-Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy. Voice: +39-051-6364147; fax: +39-051-6363080.  e-mail: renato.pasquali{at}unibo.it

A hypothetical role of glucocorticoids in human obesity has been suggested since the abdominal obesity phenotype and syndromes of endogenous or exogenous hypercortisolism share several clinical, metabolic, and cardiovascular similarities. An emerging body of evidence indicates that both neuroendocrine dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis as well as peripheral alterations of cortisol metabolism may play a role in the pathophysiology of abdominal obesity. Major alterations of the HPA axis in vivo may be identified in different ways. They include evaluation of hormone concentrations: (a) in basal conditions, in blood, urine, or saliva samples; (b) during dynamic studies following stimulation with different neuropeptides or psychological stress challenges, or suppression with inhibiting agents of the HPA axis at different levels; and (c) after mixed meals or meals containing different nutrient compositions. In addition, alteration of peripheral cortisol metabolism can be detected by direct measurement of cortisol metabolites in urine, although this is a matter of more complex investigation. Alterations of the HPA axis in abdominal obesity are associated with insulin resistance, which suggests a direct responsibility of these hormonal alterations in the susceptibility of affected patients to develop both metabolic and cardiovascular diseases. According to available data, no single marker probably has the power to detect subtle alterations of the HPA axis in conditions, such as the abdominal obesity and the metabolic syndrome. On the contrary, they indicate the need for multiple parameters. At present, evaluation of urinary free cortisol, particularly during the night-time, and salivary-free cortisol appear to be promising for these purposes, whereas dynamic tests should be reserved for specific clinical settings, involving well-characterized patients.




This article has been cited by other articles:


Home page
J. Epidemiol. Community HealthHome page
E Koch, M Bogado, F Araya, T Romero, C Diaz, L Manriquez, M Paredes, C Roman, A Taylor, and A Kirschbaum
Impact of parity on anthropometric measures of obesity controlling by multiple confounders: a cross-sectional study in Chilean women
J. Epidemiol. Community Health, May 1, 2008; 62(5): 461 - 470.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Weigensberg, C. M. Toledo-Corral, and M. I. Goran
Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1372 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. H. Stimson, A. M. Johnstone, N. Z. M. Homer, D. J. Wake, N. M. Morton, R. Andrew, G. E. Lobley, and B. R. Walker
Dietary Macronutrient Content Alters Cortisol Metabolism Independently of Body Weight Changes in Obese Men
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4480 - 4484.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
B. K. Lee, T. A. Glass, M. J. McAtee, G. S. Wand, K. Bandeen-Roche, K. I. Bolla, and B. S. Schwartz
Associations of Salivary Cortisol With Cognitive Function in the Baltimore Memory Study
Arch Gen Psychiatry, July 1, 2007; 64(7): 810 - 818.
[Abstract] [Full Text] [PDF]



footerLeft footerRight